ConocoPhillips tiene un precio objetivo de consenso de $116.89 basado en las calificaciones de 20 analistas. El máximo es $139, emitido por Truist Securities el enero 13, 2025. El mínimo es $100, emitido por Wells Fargo el octubre 17, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por UBS, Susquehanna y Wells Fargo el noviembre 12, 2025, octubre 20, 2025 y octubre 17, 2025, respectivamente. Con un precio objetivo promedio de $109 entre UBS, Susquehanna y Wells Fargo, hay una 19.05% upside implícita para ConocoPhillips según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/12/2025 | 27.79% | UBS | $122 → $117 | Maintains | Buy | |||
10/20/2025 | 20.14% | Susquehanna | $113 → $110 | Maintains | Positive | |||
10/17/2025 | 9.22% | Wells Fargo | → $100 | Initiates | → Equal-Weight | |||
10/14/2025 | 33.25% | Morgan Stanley | $123 → $122 | Maintains | Overweight | |||
10/13/2025 | 28.88% | RBC Capital | $113 → $118 | Maintains | Outperform | |||
10/07/2025 | 28.88% | Barclays | $122 → $118 | Maintains | Overweight | |||
10/06/2025 | 21.23% | Evercore ISI Group | $115 → $111 | Maintains | Outperform | |||
09/15/2025 | 31.06% | Mizuho | $125 → $120 | Maintains | Outperform | |||
09/08/2025 | 25.6% | Raymond James | $117 → $115 | Maintains | Outperform | |||
08/20/2025 | 35.43% | UBS | $116 → $124 | Maintains | Buy | |||
08/20/2025 | 27.79% | Melius Research | → $117 | Initiates | → Hold | |||
08/18/2025 | 35.43% | Piper Sandler | $123 → $124 | Maintains | Overweight | |||
08/11/2025 | 26.69% | UBS | $115 → $116 | Maintains | Buy | |||
08/11/2025 | 34.34% | Morgan Stanley | $119 → $123 | Maintains | Overweight | |||
07/23/2025 | 23.42% | Susquehanna | $114 → $113 | Maintains | Positive | |||
07/22/2025 | 27.79% | Raymond James | $109 → $117 | Maintains | Outperform | |||
07/15/2025 | 34.34% | Piper Sandler | $113 → $123 | Maintains | Overweight | |||
07/11/2025 | 25.6% | UBS | $111 → $115 | Maintains | Buy | |||
07/11/2025 | 9.22% | Scotiabank | $95 → $100 | Maintains | Sector Perform | |||
07/11/2025 | 23.42% | RBC Capital | $115 → $113 | Maintains | Outperform | |||
07/02/2025 | 23.42% | Piper Sandler | $107 → $113 | Maintains | Overweight | |||
06/26/2025 | 27.79% | Wells Fargo | $113 → $117 | Maintains | Overweight | |||
06/11/2025 | 25.6% | Citigroup | $140 → $115 | Maintains | Buy | |||
05/30/2025 | 25.6% | RBC Capital | $120 → $115 | Maintains | Outperform | |||
05/23/2025 | 15.77% | B of A Securities | $107 → $106 | Maintains | Neutral | |||
05/20/2025 | 19.05% | Raymond James | $103 → $109 | Maintains | Outperform | |||
05/14/2025 | 23.42% | Wells Fargo | $116 → $113 | Maintains | Overweight | |||
05/13/2025 | 16.86% | Piper Sandler | $114 → $107 | Maintains | Overweight | |||
05/13/2025 | 36.52% | Mizuho | $127 → $125 | Maintains | Outperform | |||
05/12/2025 | 24.51% | Susquehanna | $120 → $114 | Maintains | Positive | |||
05/09/2025 | 28.88% | Morgan Stanley | $116 → $118 | Maintains | Overweight | |||
04/29/2025 | 16.86% | B of A Securities | $138 → $107 | Downgrade | Buy → Neutral | |||
04/23/2025 | 31.06% | Barclays | $135 → $120 | Maintains | Overweight | |||
04/22/2025 | 31.06% | Susquehanna | $128 → $120 | Maintains | Positive | |||
04/16/2025 | 38.71% | Mizuho | $134 → $127 | Maintains | Outperform | |||
04/15/2025 | 21.23% | UBS | $116 → $111 | Maintains | Buy | |||
04/15/2025 | 26.69% | Wells Fargo | $131 → $116 | Maintains | Overweight | |||
04/14/2025 | 31.06% | RBC Capital | $133 → $120 | Maintains | Outperform | |||
04/11/2025 | 3.76% | Scotiabank | $115 → $95 | Maintains | Sector Perform | |||
04/07/2025 | 26.69% | UBS | $130 → $116 | Maintains | Buy | |||
03/27/2025 | 37.61% | Morgan Stanley | $131 → $126 | Maintains | Overweight | |||
03/13/2025 | 25.6% | JP Morgan | $127 → $115 | Maintains | Overweight | |||
02/12/2025 | 49.63% | UBS | $140 → $137 | Maintains | Buy | |||
02/10/2025 | 35.43% | Raymond James | $157 → $124 | Downgrade | Strong Buy → Outperform | |||
02/10/2025 | 39.8% | Wells Fargo | $132 → $128 | Maintains | Overweight | |||
02/10/2025 | 47.44% | Barclays | $137 → $135 | Maintains | Overweight | |||
01/23/2025 | 71.47% | Raymond James | $148 → $157 | Maintains | Strong Buy | |||
01/14/2025 | 44.17% | Wells Fargo | $134 → $132 | Maintains | Overweight | |||
01/13/2025 | 51.81% | Truist Securities | $138 → $139 | Maintains | Buy | |||
12/19/2024 | 24.51% | Piper Sandler | $135 → $114 | Maintains | Overweight | |||
12/16/2024 | 46.35% | Mizuho | $132 → $134 | Upgrade | Neutral → Outperform | |||
12/09/2024 | 46.35% | Wells Fargo | $131 → $134 | Maintains | Overweight | |||
12/06/2024 | 80.21% | Evercore ISI Group | → $165 | Reinstates | → Outperform | |||
12/04/2024 | 34.34% | JP Morgan | $120 → $123 | Upgrade | Neutral → Overweight | |||
11/01/2024 | 44.17% | Mizuho | $129 → $132 | Maintains | Neutral | |||
11/01/2024 | 61.64% | Susquehanna | $144 → $148 | Maintains | Positive | |||
11/01/2024 | 49.63% | Barclays | $135 → $137 | Maintains | Overweight | |||
10/18/2024 | 57.27% | Susquehanna | $147 → $144 | Maintains | Positive | |||
10/11/2024 | 37.61% | JP Morgan | $139 → $126 | Assumes | Neutral → Neutral | |||
10/10/2024 | 25.6% | Scotiabank | $120 → $115 | Maintains | Sector Perform | |||
10/04/2024 | 36.52% | BMO Capital | $123 → $125 | Maintains | Outperform | |||
10/03/2024 | 47.44% | Barclays | $156 → $135 | Maintains | Overweight | |||
09/30/2024 | 50.72% | Truist Securities | $145 → $138 | Maintains | Buy | |||
09/27/2024 | 44.17% | Wells Fargo | $150 → $132 | Maintains | Overweight | |||
09/18/2024 | 52.91% | UBS | $153 → $140 | Maintains | Buy | |||
09/16/2024 | 40.89% | Mizuho | $132 → $129 | Maintains | Neutral | |||
09/13/2024 | 52.91% | RBC Capital | $140 → $140 | Reiterates | Outperform → Outperform | |||
09/04/2024 | 60.55% | Susquehanna | $154 → $147 | Maintains | Positive | |||
08/20/2024 | 67.1% | UBS | $151 → $153 | Maintains | Buy | |||
08/06/2024 | 64.92% | UBS | $159 → $151 | Maintains | Buy | |||
08/02/2024 | 63.83% | Wells Fargo | $151 → $150 | Maintains | Overweight | |||
08/02/2024 | 58.37% | Truist Securities | $147 → $145 | Maintains | Buy | |||
07/22/2024 | 60.55% | Truist Securities | $165 → $147 | Maintains | Buy | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Outperform | |||
07/17/2024 | 44.17% | Bernstein | $147 → $132 | Maintains | Outperform | |||
07/12/2024 | 31.06% | Scotiabank | $135 → $120 | Maintains | Sector Perform | |||
06/14/2024 | 60.55% | B of A Securities | → $147 | Reinstates | → Buy | |||
06/05/2024 | 44.17% | Mizuho | $142 → $132 | Maintains | Neutral | |||
06/03/2024 | 80.21% | Truist Securities | $160 → $165 | Maintains | Buy | |||
05/30/2024 | 74.75% | Barclays | $158 → $160 | Maintains | Overweight | |||
05/30/2024 | 73.66% | Raymond James | $155 → $159 | Reiterates | Strong Buy → Strong Buy | |||
05/15/2024 | 52.91% | RBC Capital | $135 → $140 | Maintains | Outperform | |||
05/13/2024 | 55.09% | Mizuho | $139 → $142 | Maintains | Neutral | |||
05/03/2024 | 64.92% | Wells Fargo | $149 → $151 | Maintains | Overweight | |||
04/29/2024 | 74.75% | Truist Securities | $170 → $160 | Maintains | Buy | |||
04/22/2024 | 68.2% | Susquehanna | $133 → $154 | Maintains | Positive | |||
04/18/2024 | 71.47% | Piper Sandler | $145 → $157 | Maintains | Overweight | |||
04/11/2024 | 47.44% | Scotiabank | $120 → $135 | Maintains | Sector Perform | |||
04/10/2024 | 62.73% | Wells Fargo | $141 → $149 | Maintains | Overweight | |||
04/10/2024 | 72.56% | Barclays | → $158 | Initiates | → Overweight | |||
04/05/2024 | 85.67% | Truist Securities | $173 → $170 | Maintains | Buy | |||
03/28/2024 | 40.89% | Morgan Stanley | $123 → $129 | Maintains | Overweight | |||
03/22/2024 | 51.81% | Mizuho | $132 → $139 | Reiterates | Neutral → Neutral | |||
03/14/2024 | 45.26% | Piper Sandler | $139 → $133 | Maintains | Overweight | |||
02/14/2024 | 56.18% | UBS | $138 → $143 | Maintains | Buy | |||
02/09/2024 | 31.06% | Scotiabank | $115 → $120 | Maintains | Sector Perform | |||
01/26/2024 | 45.26% | Susquehanna | $152 → $133 | Maintains | Positive | |||
01/24/2024 | 49.63% | Raymond James | $140 → $137 | Maintains | Strong Buy | |||
01/03/2024 | 44.17% | Mizuho | $139 → $132 | Maintains | Neutral | |||
12/29/2023 | 52.91% | Raymond James | $146 → $140 | Maintains | Strong Buy |
El último precio objetivo de ConocoPhillips (NYSE:COP) fue comunicado por UBS el noviembre 12, 2025. La firma de analistas fijó un precio objetivo para $117.00 que espera COP a rise dentro de 12 meses (un posible 27.79% upside). 54 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para ConocoPhillips (NYSE:COP) fue proporcionada por UBS, y ConocoPhillips mantuvo su buy calificación.
La última revisión al alza de ConocoPhillips se produjo en diciembre 16, 2024, cuando Mizuho elevó su precio objetivo a $134. Mizuho anteriormente tenía a neutral para ConocoPhillips.
La última revisión a la baja de ConocoPhillips se produjo en abril 29, 2025, cuando B of A Securities cambió su precio objetivo de $138 a $107 para ConocoPhillips.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de ConocoPhillips, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de ConocoPhillips se registró el noviembre 12, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 12, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de ConocoPhillips (COP) fue un mantuvo con un precio objetivo de $122.00 a $117.00. El precio actual al que cotiza ConocoPhillips (COP) es de $91.56, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.